Nucleic Acid Labeling Market size to Reach USD 4.09 Billion by 2031, Driven by Shift Toward Safer Labeling Methods

June 20 14:33 2026
Nucleic Acid Labeling Market size to Reach USD 4.09 Billion by 2031, Driven by Shift Toward Safer Labeling Methods
Mordor Intelligence has published a new report on the nucleic acid labeling market, offering a comprehensive analysis of trends, growth drivers, and future projections.

Introduction

According to recent analysis, the nucleic acid labeling market size is estimated at USD 2.85 billion in 2026 and is projected to reach USD 4.09 billion by 2031, growing at a CAGR of 7.48% during the forecast period. This upward trajectory reflects increasing adoption of DNA and RNA labeling techniques across research and clinical settings.

A major factor influencing the nucleic acid labeling market growth is the transition from traditional radioactive labeling approaches toward safer and more efficient alternatives. Laboratories are increasingly favoring non-radioactive techniques that allow accurate detection while minimizing risks to researchers and samples. At the same time, the nucleic acid labeling industry benefits from strong funding support in genomics and biotechnology, encouraging innovation and wider use of labeling tools.

Key Trends Shaping the Nucleic Acid Labeling Market

Shift Toward Non-Radioactive Labeling Methods

One of the most notable nucleic acid labeling market trends is the growing preference for non-radioactive labeling techniques. Fluorescent labeling remains widely used due to its safety, ease of use, and compatibility with automated systems. These methods allow researchers to work efficiently without handling hazardous materials, making them suitable for high-throughput environments.

Adoption of Click-Chemistry and Bioorthogonal Techniques

Another important trend in the nucleic acid labeling industry is the adoption of click-chemistry and bioorthogonal labeling platforms. These techniques enable the tagging of nucleic acids in living cells without interfering with biological processes. The ability to label DNA and RNA in real-time is improving research accuracy and expanding possibilities in cellular studies.

Growth of CRISPR-Based Diagnostics

CRISPR technologies are influencing the nucleic acid labeling market growth by introducing highly sensitive diagnostic methods. These systems often eliminate the need for amplification steps, making testing faster and more efficient. Labeling plays a key role in detecting genetic material in such platforms, supporting their integration into clinical workflows.

Increasing Role of Contract Research Organizations

Contract research organizations are gaining traction within the nucleic acid labeling market as pharmaceutical and biotechnology companies outsource complex labeling tasks. These organizations provide specialized expertise and infrastructure, enabling efficient handling of advanced labeling requirements while meeting regulatory standards.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/nucleic-acid-labeling-market?utm_source=abnewswire

Nucleic Acid Labeling Market Segmentation

By Label Type

  • Biotin-based

  • Fluorescent

  • Radioactive (32P, 35S, etc.)

  • Other Label Types

By Product

  • Reagents & Kits

  • Probes & Primers

  • Enzymes & Polymerases

  • Custom Labeling Services

By Method

  • Direct Chemical Labeling

  • PCR-based Incorporation

  • Nick Translation / Random Priming

  • Click-Chemistry Conjugation

By Application

  • Microarray & Gene Expression

  • Next-Generation Sequencing (NGS)

  • In-situ Hybridization / FISH

  • Polymerase Chain Reaction (PCR/qPCR)

  • CRISPR Screening & Diagnostics

  • Other Applications

By End User

  • Academic & Research Institutes

  • Hospitals & Clinics

  • Diagnostic Laboratories

  • Biopharma & Biotechnology Companies

  • CROs & Service Providers

By Geography

  • North America

  • Europe

  • Asia-Pacific

  • Middle East & Africa

  • South America

Key Players in the Nucleic Acid Labeling Market

  • GE Healthcare

  • Merck KGaA

  • PerkinElmer Inc.

  • Promega Corporation

  • Thermo Fisher Scientific, Inc.

Conclusion

The nucleic acid labeling market is set to maintain steady growth as advancements in genomics and molecular diagnostics continue to create new opportunities. The transition toward safer labeling techniques, combined with increasing research activity, is strengthening the foundation of the nucleic acid labeling industry.

Looking ahead, the nucleic acid labeling market growth will be influenced by the integration of labeling technologies into next-generation diagnostic platforms and personalized medicine approaches. As laboratories seek faster and more precise methods, the demand for innovative labeling solutions is expected to rise.

The nucleic acid labeling market trends indicate a balanced mix of traditional and modern approaches, ensuring flexibility across applications. With expanding use in research, diagnostics, and therapeutics, the nucleic acid labeling market forecast remains positive, supported by continuous demand for accurate genetic analysis tools.

Industry Related Reports

Non-Viral Drug Delivery Systems Market:

The non-viral drug delivery systems market is growing due to increasing demand for safer and more efficient delivery methods for genetic therapies. Advancements in lipid nanoparticles and rising applications in oncology and mRNA-based treatments are driving market growth.

Get more insights: https://www.mordorintelligence.com/industry-reports/non-viral-drug-delivery-systems-market?utm_source=abnewswire

Cell-Free Protein Expression Market size:

The market is projected to grow from USD 339.72 million in 2026 to USD 499.73 million by 2031 at a CAGR of 8.02%. Growth is driven by increasing demand for rapid protein production, advancements in synthetic biology, and expanding research applications.

Get more insights: https://www.mordorintelligence.com/industry-reports/cell-free-protein-expression-market?utm_source=abnewswire

SNP Genotyping Market share:

The market is expected to grow from USD 8.57 billion in 2026 to USD 10.19 billion by 2031 at a CAGR of 3.52%. Growth is fueled by rising adoption in genetic research, personalized medicine, and increasing demand for advanced diagnostic tools.

Get more insights: https://www.mordorintelligence.com/industry-reports/snp-genotyping-market?utm_source=abnewswire

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

[email protected] https://www.mordorintelligence.com/

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email: Send Email
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/

view more articles

About Article Author